Anila Kompanachalil Parameswaran Nair

Anila Kompanachalil Parameswaran Nair

Auto-generated profile, based on publicly available information

Anila Kompanachalil Parameswaran Nair

Department of Medical Surgical Nursing, Amrita College of Nursing, Amrita Vishwa Vidyapeetham, Amrita Institute of Medical Sciences and Research Center, Kochi Campus, Ponekkara, Edappally, Kochi, Kerala, 682041, India, 91 8335053920

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2026 in Nursing Forum
Verified
Journal Article
Open access
PDF file
MMManila Mathews
Manila Mathews
KMKaippaplakal Thamikkutty Moly
Kaippaplakal Thamikkutty Moly
ANAnila Kompanachalil Parameswaran Nair
Anila Kompanachalil Parameswaran Nair
MJMariam Odathakal Joseph
Mariam Odathakal Joseph
JAJudie Arulappan
Judie Arulappan
Background: Preterm infants are at increased risk of long‐term cognitive, motor, and behavioral impairments due to disrupted brain development. Although various early developmental interventions have been implemented to improve neurodevelopmental outcomes, evidence on their effectiveness remains inconsistent due to variations in intervention types, timing, duration, delivery methods, and caregiver involvement. Furthermore, recent evidence evaluating healthcare provider–led and caregiver‐led interventions has not been comprehensively synthesized. This systematic review addresses this gap by evaluating the effectiveness of early developmental interventions on neurodevelopmental outcomes in preterm infants. Objective: This study was conducted to evaluate the effectiveness of early developmental interventions, including healthcare provider–led and caregiver‐mediated interventions, on the cognitive, motor, and behavioral outcomes of preterm infants compared with standard care. This systematic review was registered with PROSPERO (CRD42025646308) on February 14, 2025. Methods: This systematic review was conducted in accordance with the Preferred Reporting Items for Systematic Reviews and Meta‐Analyses (PRISMA) 2020 guidelines. A comprehensive literature search was performed in PubMed, Scopus, Web of Science, CINAHL, and EBSCO to identify studies evaluating the effects of early developmental interventions on the neurodevelopmental outcomes of preterm infants. The search included studies published between June 2015 and May 2025. A combination of keywords and Medical Subject Headings (MeSH) terms related to preterm infants, early developmental interventions, and neurodevelopmental outcomes was used. Randomized controlled trials and cohort studies that met the predefined eligibility criteria were included. The Revised Cochrane Risk‐of‐Bias Tool for Randomized Trials (RoB 2) and the Newcastle‐Ottawa Quality Assessment Scale for cohort studies were used to assess the risk of bias. Owing to the heterogeneity of interventions, outcome measures, and follow‐up periods, a narrative synthesis of the findings was undertaken. Results: Nine studies were included, comprising eight randomized controlled trials and one cohort study. Motor development was assessed in four studies; only one study (25%) reported significant improvements following a home‐based postdischarge intervention, whereas the remaining three studies found no significant between‐group differences despite within‐group gains. Cognitive outcomes were evaluated in six studies; none demonstrated significant long‐term cognitive improvements compared with standard care, although some reported trends toward age‐appropriate development or short‐term gains. Behavioral outcomes were assessed in two studies; one reported improved early personal–social and communication skills following parent‐supported physiotherapy, whereas the other found no direct intervention effect and identified maternal parenting stress as a significant predictor of adverse behavioral outcomes. Overall, interventions that actively engaged parents and incorporated psychosocial support demonstrated the most promising effects on motor and behavioral development, whereas evidence for cognitive benefits remained limited. Discussion: The available evidence suggests that early developmental interventions may support selected neurodevelopmental outcomes in preterm infants, particularly motor and behavioral development when interventions actively involve parents. However, evidence for cognitive benefits remains inconsistent, and substantial heterogeneity in intervention approaches, outcome measures, and follow‐up periods limits definitive conclusions. Further high‐quality, adequately powered randomized controlled trials with standardized interventions and long‐term follow‐up are needed to establish the effectiveness of these interventions.

4 August 2026 in JMIR Research Protocols
Verified
Journal Article
Open access
SKSalini K
Salini K
ALAjee K L
Ajee K L
PVPraveen Kerala Varma
Praveen Kerala Varma
BPB Premjith
B Premjith
APAnila K P
Anila K P
NNNamrata Nair
Namrata Nair
Background: Thirty-day unplanned readmission following coronary artery bypass grafting (CABG) affects 10%-20% of patients and is a key quality indicator, particularly in low- and middle-income countries (LMICs) where access to cardiac rehabilitation is limited. Existing risk models are static, lack real-time engagement, and no validated large language model (LLM)–based clinical decision support (CDS) system exists for post-CABG readmission prevention. Objective: This protocol describes the development, validation, and evaluation of Smart CABGuard, a nurse-led, LLM-based CDS chatbot with continuous remote electrocardiographic (ECG) monitoring, to predict and prevent postoperative complications, and 30-day unplanned readmission after isolated CABG. Methods: This multiphase translational study is conducted at Amrita Institute of Medical Sciences, Kochi, India, following TRIPOD-LLM (Transparent Reporting of a Multivariable Prediction Model for Individual Prognosis or Diagnosis–Large Language Model) and CONSORT (Consolidated Standards of Reporting Trials) AI reporting guidelines. Phase I uses an ambispective design (retrospective: January 2020 to December 2024; prospective needs survey: June 2025 to January 2026) to develop a logistic regression-based Complication Risk Index (CRI), assessed via receiver operating characteristic area under the curve, Brier score, and decision curve analysis. Phase II refines Smart CABGuard by integrating a frozen Mistral-7B LLM (low-rank adaptation fine-tuned), the CRI engine, explainable AI, and single-lead ECG telemetry (Amrita Spandanam device), with a usability threshold of ≥80%. Phase III is a prospective, parallel-group, open-label randomized controlled trial (RCT). Adults aged ≥18 years undergoing isolated CABG with smartphone access are randomized 1:1 via permuted block randomization, with allocation concealment. The intervention arm receives Smart CABGuard–assisted care (daily chatbot check-ins, CRI-based risk stratification, ECG monitoring, and nurse-led triage) for approximately 24 days postdischarge plus standard care; the control arm receives standard care with structured telephone follow-up for outcome ascertainment only. Outcome assessors and statisticians are blinded; analyses follow the intention-to-treat principle. The primary outcome is 30-day all-cause unplanned readmission. Based on a baseline rate of 10.71%, a 50% relative reduction, α=.10, and 80% power, the target sample size is 800 patients (400 per arm, including 10% attrition). Results: Ethics approval was granted by the Institutional Ethics Committee of Amrita Institute of Medical Sciences on April 16, 2025. Funding was awarded by Sigma Theta Tau International Honor Society of Nursing, Small Grants Program (grant 21650) in June 2025. Phase I data extraction commenced in May 2025 and is projected to be completed by April 2026; the patient needs survey (June 2025 to January 2026) is ongoing. Phase II usability evaluation is projected from May to July 2026. Phase III recruitment is anticipated from August 2026 to September 2027. Results are expected to be published in early 2028. Conclusions: Smart CABGuard is the first RCT protocol of an LLM-based nurse-led CDS system for post-CABG readmission prevention in an LMIC setting, aiming to establish the usefulness, safety, and feasibility of AI-augmented postoperative surveillance.